Orthofix Medical (OFIX) Share-based Compensation Growth (3y) (2013 - 2026)
Orthofix Medical (OFIX) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.56% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 13.40% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthofix Medical | 443.33 Mn | 322.46 Mn | 139.55 Mn | -20.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.54% |
| Dec 31, 2025 | 79.61% |
| Sep 30, 2025 | -87.61% |
| Jun 30, 2025 | -50.59% |
| Mar 31, 2025 | 14.30% |
| Dec 31, 2024 | -91.68% |
| Sep 30, 2024 | 77.58% |
| Jun 30, 2024 | -48.67% |
| Mar 31, 2024 | 33.23% |
| Dec 31, 2023 | -39.32% |
| Sep 30, 2023 | 97.02% |
| Jun 30, 2023 | -60.01% |
| Mar 31, 2023 | 357.46% |
| Dec 31, 2022 | 5.75% |
| Sep 30, 2022 | -6.81% |
| Jun 30, 2022 | -8.64% |
| Mar 31, 2022 | -8.66% |
| Dec 31, 2021 | 53.96% |
| Sep 30, 2021 | -9.95% |
| Jun 30, 2021 | -9.18% |